We're so confident of our products that we provide no hassle product exchange.
NBMTM BCMTMS Exam Overview:
| Certification Vendor: | National Board of Medication Therapy Management (NBMTM) |
| Exam Name: | Board Certified Medication Therapy Management Specialist Examination |
| Exam Number: | BCMTMS |
| Exam Format: | Multiple-choice questions, Closed-book, Proctored, Two parts (100 questions each, 2 hours per part) |
| Exam Duration: | 240 minutes |
| Real Exam Qty: | 200 |
| Passing Score: | Determined via Angoff Method, scaled score; varies slightly by exam form |
| Exam Price: | $450 USD (standard), $550 USD (late registration) |
| Available Languages: | English |
| Certificate Validity Period: | 5 years |
| Recommended Training: | Power-Pak C.E. MTM Certificate Program APhA Delivering Medication Therapy Management Services |
| Exam Registration: | NBMTM myNBMTM Portal |
| Sample Questions: | NBMTM BCMTMS Sample Questions |
| Exam Way: | Online remote proctored or onsite testing center; administered by Meazure Learning |
| Pre Condition: | Active unrestricted pharmacist license; plus either 2 years post-licensure practice experience in MTM or completion of an NBMTM-approved MTM training program |
| Official Syllabus URL: | https://www.nbmtm.org/bcmtms-exam-overview/ |
NBMTM BCMTMS Exam Syllabus Topics:
| Section | Weight | Objectives |
|---|---|---|
| Documentation and Billing | 7% | - Required documentation standards for MTM services - Coding, billing, and reimbursement rules - Compliance and regulatory requirements |
| Defining Medication Therapy Management and Translating MTM into Practice | 13% | - Core concepts and definitions of MTM - Models and frameworks for delivering MTM services - Integration of MTM within healthcare systems and practice settings |
| Pharmacotherapy | 62% | - Patient-specific pharmacotherapy optimization - Medication safety, drug interactions, and therapeutic alternatives - Disease state management and evidence-based treatment guidelines - Drug selection, dosing, monitoring, and adverse effect prevention |
| Patient Care Advocacy | 13% | - Care coordination and collaboration with providers - Adherence support and barrier resolution - Health literacy and cultural competence - Patient education and communication strategies |
| Fundamentals of Pharmacogenomics | 5% | - Basic principles of pharmacogenomics - Impact of genetic variations on drug response and metabolism - Application of pharmacogenomic data in clinical decision-making |
NBMTM Board Certified Medication Therapy Management Specialist Sample Questions:
1. Which guideline BE ST describes a daily nutrient goal for a patient who is following the DASH diet?
A) Protein intake should De at least 55% of total daily calories.
B) Sodium intake should be no more than 2300mg daily
C) Fiberintake should be between Gg and 10g daily
D) Saturated fat intake should be no more than 17% of total daily calories
2. A pharmacist places the following note in the Plan section or a patients soap note:
'Recommend patient increase ibuprofen 200mg to q.I.d scheduled dose Patient agrees.
Which description of an error with this note is most accurate?
A) It introduces new Information that should be included in the Subjective section
B) it is missing a follow-up and monitoring plan
C) it includes irrelevant information mat should have been excluded.
D) it should have been placed in the Objective section.
3. A patient is participating in an MTM session snares that they are taking hydrocodone/acetaminopen iomg
/325mg four times daily for the last year due to chronic back pain The patient complains of constipation even after taking senna/docusate supplements for the last month and describes bloating, cramps, and an Inability to have a bowel movement for the pant five days Which reaction by the pharmacist to the patients concern would be BEST?
A) Advise the patient 10 try the senna/docusate supplement for a few more weeks.
B) Advise the patient to eat more fiber and stay hydrated
C) Recommend the patient try a psyllium laxative.
D) Refer the patient to a physician to rule out a bowel obstruction
4. A patient who is taking cannabidiol for seizures associated with Lennox-Gastaut syndrome should have specific lab values tracked closely during therapy to monitor for which potential effect?
A) Hepatotoxicity
B) Intoxication syndrome
C) Nephrotoxicity
D) Pancreatitis
5. in premature infants, which factor affecting medication absorption needs to be considered?
A) Stomach size
B) Saliva enzymes
C) Gastric pH
D) Kidney size
Solutions:
| Question # 1 Answer: A | Question # 2 Answer: B | Question # 3 Answer: B | Question # 4 Answer: C | Question # 5 Answer: D |
By Isaac
